280 related articles for article (PubMed ID: 2650578)
21. Pentoxifylline for intermittent claudication.
Med Lett Drugs Ther; 1984 Nov; 26(675):103-4. PubMed ID: 6390108
[No Abstract] [Full Text] [Related]
22. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
Gillings DB
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group.
Int Angiol; 1996 Mar; 15(1):75-80. PubMed ID: 8739541
[TBL] [Abstract][Full Text] [Related]
24. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
Ganança MM; Mangabeira Albernaz PL; Caovilla HH; Ito YI
Pharmatherapeutica; 1988; 5(3):170-6. PubMed ID: 3283777
[TBL] [Abstract][Full Text] [Related]
25. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
[TBL] [Abstract][Full Text] [Related]
26. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
27. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
[TBL] [Abstract][Full Text] [Related]
28. Intermittent claudication in diabetics: treatment with exercise and pentoxifylline--a 6-month, controlled, randomized trial.
Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Cesarone MR; Incandela L; Ippolito E; Pomante P; Geroulakos G; Ramaswami G
Angiology; 2002; 53 Suppl 1():S39-43. PubMed ID: 11865835
[TBL] [Abstract][Full Text] [Related]
29. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
[TBL] [Abstract][Full Text] [Related]
30. [Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities].
Pokrovskiĭ AV; Chupin AV; Kalinin AA; Markosian AA; Zamskiĭ KS; Kolosov RV
Angiol Sosud Khir; 2003; 9(2):19-24. PubMed ID: 12811370
[TBL] [Abstract][Full Text] [Related]
31. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
Clement DL; Duprez D
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S89-95. PubMed ID: 2446082
[TBL] [Abstract][Full Text] [Related]
32. [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
Rudofsky G; Brock FE; Ulrich M; Nobbe F
Med Klin; 1979 Jul; 74(28-29):1093-6. PubMed ID: 556192
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
[TBL] [Abstract][Full Text] [Related]
34. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
35. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
[TBL] [Abstract][Full Text] [Related]
36. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
[TBL] [Abstract][Full Text] [Related]
37. Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
Johnson WC; Watkins MT; Hamilton J; Baldwin D; Walker N
Surgery; 1994 Jun; 115(6):735-9. PubMed ID: 8197567
[TBL] [Abstract][Full Text] [Related]
38. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of vascular diseases of the extremities using pentoxifylline].
Di Perri T
Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
[No Abstract] [Full Text] [Related]
40. Pentoxifylline in the nonoperative management of intermittent claudication.
Kokesh J; Kazmers A; Zierler RE
Ann Vasc Surg; 1991 Jan; 5(1):66-70. PubMed ID: 1997079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
